European Commission Approves Pfizer’s CCR5 Inhibitor Maraviroc
Sep 28th 2007Drug InformationHIV / AIDS
Pfizer on Monday announced that the European Commission has approved its antiretroviral drug Celsentri, known generically as maraviroc, for sale and marketing in the European Union, Dow Jones/CNNMoney.com reports (Berton, Dow Jones/CNNMoney. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
